Lin, D.; Yu, W.; Yu, J.; Cheng, S.; Song, Y.; Wan, X.; Xu, Y.; Luo, H.; Sun, B.
Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals 2025, 18, 428.
https://doi.org/10.3390/ph18030428
AMA Style
Lin D, Yu W, Yu J, Cheng S, Song Y, Wan X, Xu Y, Luo H, Sun B.
Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals. 2025; 18(3):428.
https://doi.org/10.3390/ph18030428
Chicago/Turabian Style
Lin, Dengxiao, Wenfeng Yu, Jia Yu, Sha Cheng, Yu Song, Xiaoqing Wan, Yingjiang Xu, Heng Luo, and Baofei Sun.
2025. "Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets" Pharmaceuticals 18, no. 3: 428.
https://doi.org/10.3390/ph18030428
APA Style
Lin, D., Yu, W., Yu, J., Cheng, S., Song, Y., Wan, X., Xu, Y., Luo, H., & Sun, B.
(2025). Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals, 18(3), 428.
https://doi.org/10.3390/ph18030428